MEADE HARRY 4
4 · GTC BIOTHERAPEUTICS INC · Filed Dec 13, 2004
Insider Transaction Report
Form 4
MEADE HARRY
SVP, Transgenic Research
Transactions
- Award
Common Stock (right to buy)
2004-12-09+1,000→ 1,000 totalExercise: $2.25Exp: 2014-12-08→ Common Stock (1,000 underlying)
Footnotes (1)
- [F1]200 options vested on December 9, 2004, the remaining 800 options vest in equal annual installments on each of December 9, 2005, 2006, 2007 and 2008, subject to possible acceleration upon the satisfaction of certain conditions.